Early Serum Infliximab Levels in Severe Ulcerative Colitis

Trial Profile

Early Serum Infliximab Levels in Severe Ulcerative Colitis

Phase of Trial: Phase I

Latest Information Update: 09 Jun 2015

At a glance

  • Drugs Infliximab (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Acronyms EaSiFx
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 May 2015 Status changed from recruiting to completed according to ClinicalTrials.gov record.
    • 03 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top